These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3566358

  • 1. Endocrine and clinical effects of spironolactone in female hyperandrogenism.
    Siegberg R, Ylöstalo P, Laatikainen T, Pelkonen R, Stenman UH.
    Arch Gynecol; 1987; 240(2):67-73. PubMed ID: 3566358
    [Abstract] [Full Text] [Related]

  • 2. Effect of a combination of ethinylestradiol and desogestrel in adolescents with oligomenorrhea and ovarian hyperandrogenism.
    Nappi C, Farace MJ, Leone F, Minutolo M, Tommaselli AP, Montemagno U.
    Eur J Obstet Gynecol Reprod Biol; 1987 Jul; 25(3):209-19. PubMed ID: 2956138
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of hirsutism with spironolactone.
    Cumming DC, Yang JC, Rebar RW, Yen SS.
    JAMA; 1982 Mar 05; 247(9):1295-8. PubMed ID: 7199587
    [Abstract] [Full Text] [Related]

  • 8. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec 05; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low dose spironolactone in the treatment of female hyperandrogenemia and hirsutism.
    Vĕtr M, Sobek A.
    Acta Univ Palacki Olomuc Fac Med; 1993 Dec 05; 135():55-7. PubMed ID: 7976677
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dexamethasone and spironolactone in the treatment of non-tumorous hyperandrogenism.
    Prezelj J, Kocijancic A, Andolsek L.
    Gynecol Endocrinol; 1989 Dec 05; 3(4):281-8. PubMed ID: 2516705
    [Abstract] [Full Text] [Related]

  • 15. Therapeutic effects of spironolactone in polycystic ovary syndrome.
    Milewicz A, Silber D, Kirschner MA.
    Obstet Gynecol; 1983 Apr 05; 61(4):429-32. PubMed ID: 6828272
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
    Marcondes JA, Minanni SL, Luthold WW, Lerário AC, Nery M, Mendonça BB, Wajchenberg BL, Kirschner MA.
    J Endocrinol Invest; 1995 Jun 05; 18(6):431-5. PubMed ID: 7594237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: a multicenter, double blind, placebo-controlled trial.
    Azziz R, Ehrmann D, Legro RS, Whitcomb RW, Hanley R, Fereshetian AG, O'Keefe M, Ghazzi MN, PCOS/Troglitazone Study Group.
    J Clin Endocrinol Metab; 2001 Apr 05; 86(4):1626-32. PubMed ID: 11297595
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.